UCHL1 Proteins, Antibodies, cDNA Clones Research Reagents

All UCHL1 reagents are produced in house and quality controlled, including 11 UCHL1 Antibody, 90 UCHL1 Gene, 6 UCHL1 IP Kit, 3 UCHL1 Protein, 3 UCHL1 qPCR. All UCHL1 reagents are ready to use.

UCHL1 Protein (3)

    UCHL1 Antibody (11)

      More Product Popular With Customers

      UCHL1 Background

      Ubiquitin carboxyl-terminal hydrolase isozyme L1, also known as UCH-L1, Ubiquitin thioesterase L1, PGP9.5 and UCHL1, is a deubiqutinating enzyme with important functions in recycling of ubiquitin. Regulated proteolysis by the ubiquitin pathway has been implicated in control of the cell cycle, transcriptional activation, cell fate and growth, and synaptogenesis. The ubiquitin-proteasome system is involved in synaptic plasticity and is proposed to be part of a molecular switch that converts short-term synaptic potentiation to long-term changes in synaptic strength. UCHL1 is found in neuronal cell bodies and processes throughout the neocortex (at protein level). It is expressed in neurons and cells of the diffuse neuroendocrine system and their tumors. UCHL1 is weakly expressed in ovary. UCHL1 is a ubiquitin-protein hydrolase. It is involved both in the processing of ubiquitin precursors and of ubiquitinated proteins. This enzyme is a thiol protease that recognizes and hydrolyzes a peptide bond at the C-terminal glycine of ubiquitin. UCHL1 also binds to free monoubiquitin and may prevent its degradation in lysosomes. The homodimer of UCHL1 may have ATP-independent ubiquitin ligase activity. UCHL1 dysfunction has been associated with neurodegeneration in Parkinson's, Alzheimer's, and Huntington's disease patients. Reduced UCHL1 function may jeopardize the survival of CNS neurons.

      UCHL1 References

      • Wada H., et al., 1998, Biochem. Biophys. Res. Commun. 251:688-92.
      • Choi J., et al., 2004, J. Biol. Chem. 279:13256-64.
      • Lombardino,A.2005, et al., J.Proc Natl Acad Sci.USA102 (22):8036-41
      • Okochi-Takada,E. et al., 2006, Int J Cancer. 119 (6):1338-44.
      • Zetterberg, M. et al., 2010, Mol Neurodegener  5 :11.

      Note: Flag® is a registered trademark of Sigma Aldrich Biotechnology LP. It is used here for informational purposes only.